IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Completed

Conditions studied: ADHD, HIV

In brief

The main purpose of this study is to find out how stimulant medications (methylphenidate or amphetamine/ dextroamphetamine) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)are processed in HIV-1 infected and HIV-uninfected children and adolescents.

Key facts

Study ID
NCT01232361
Run by
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
People needed
127
Starts
2010-10-08
Expected to finish
2016-07-01
Last updated by the study team
2021-08-03

Who can join

Age: 6 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.